Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vaneck Biotech ETF (NQ: BBH )

155.59 +0.82 (+0.53%)
Official Closing Price Updated: 4:15 PM EDT, Apr 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,398
Open 154.55
Bid (Size) 155.59 (1)
Ask (Size) 155.68 (1)
Prev. Close 154.77
Today's Range 154.55 - 156.17
52wk Range 142.51 - 171.04
Shares Outstanding N/A
Dividend Yield 0.48%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
VanEck Announces Year-End Distributions for VanEck Equity ETFs
From VanEck
Via Business Wire
Time For Gilead Sciences-Heavy ETFs?
Gilead Sciences has underperformed the broader market this year by a hefty margin. 
Via Talk Markets

Performance

YTD
-8.11%
-8.11%
1 Month
-5.78%
-5.78%
3 Month
-6.88%
-6.88%
6 Month
+5.55%
+5.55%
1 Year
-1.39%
-1.39%

More News

Read More
Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
Via Benzinga
Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules
Via Benzinga
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
Via Benzinga
Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
Via Benzinga
FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits
Via Benzinga
VanEck Launches Robotics ETF (IBOT)
From VanEck
Via Business Wire
US Judge Weighs Nationwide Ban On Abortion Pills
Via Benzinga
FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug'
Via Benzinga
3 Best Funds for Aggressive Investors
Via InvestorPlace
Progenity Is Unlikely to Live Up to Its IPO Hype
Via InvestorPlace
Economic Hurricane Ahead? 7 Profitable Places to Hide Your Money
Via InvestorPlace
How Are Biotech ETFs Reacting To These Q3 Earnings Releases?
Via Talk Markets
Novavax Stock Is a Buy for Long-Term Investors on Its Pipeline Alone
Via InvestorPlace
Take A Look At The Top-Performing Biotech ETFs YTD
Via Talk Markets
Exposures COVID-19
Biotech ETFs To Benefit From Latest Booster Update
Via Talk Markets
Exposures COVID-19
ETF Investing Areas to Consider for August
Via Talk Markets
Moderna ETFs To Rise On Positive COVID-19 Vaccine Updates
Via Talk Markets
Exposures COVID-19
5 Top ETFs With Exposure To Biogen
Via Talk Markets
5 Top ETFs With Exposure To Biogen
Via Benzinga
Exposures Product Safety
Biotech ETFs To Suffer As US Backs IP Waiver For COVID-19 Vaccines
Via Talk Markets
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Moderna Stock Moves After Q1 Print: Technical Levels For The COVID-19 Vaccine Play
Via Benzinga
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.